Brain and other central nervous system tumours are cancers of poor prognosis, for which current therapeutic possibilities do not match the expectations regarding a curative objective. If the treatment of central nervous system tumours is so difficult, it is partly due to the blood-brain barrier and the blood-tumour barrier, which need to be crossed to access the tumour. Driven by these insufficient results, more and more techniques and technologies are being explored and are evolving: the progress of surgery and radiotherapy, the growing place of immunotherapies, or the apparition of new non-invasive techniques.
View Article and Find Full Text PDFBull Soc Med Afr Noire Lang Fr
July 1976
Bull Soc Med Afr Noire Lang Fr
December 1975
Bull Soc Med Afr Noire Lang Fr
December 1975